Point-of-care immunoassay for early diagnosis of pertussis

Active Project Grant Awarded Last action

Award ID
R44AI109891
Recipient
Awarding agency
Obligated
$8,150,612

Award facts

Assistance listing
93.855 Allergy and Infectious Diseases Research
Completion date 96% complete
Originally
Place of performance
Reno, NV 89557, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $0
Amendment $0
Amendment $0
Amendment $989,461
Amendment $989,461
Amendment $999,716
Amendment $999,716
Amendment $0
Amendment $0
Amendment Point-of-care lateral flow immunoassay for diagnosis of pertussis - pertussis (whooping cough) is a highly contagious, airborne disease that is rapidly… $0
Amendment $1,009,408
Amendment $1,009,408
Amendment Point-of-care lateral flow immunoassay for diagnosis of pertussis $1,009,408
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $289,172
Amendment -$46,837
Amendment $351,332
Amendment $143,827
Original award $406,540
Show all 22

Quick answers

Who received award R44AI109891?

R44AI109891 was awarded to Dxdiscovery, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on June 1, 2014.

How much is award R44AI109891 worth?

$8,150,612 has been obligated on R44AI109891.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award